Market Cap

Kancera AB Market Capitalization:

kr370.4 Million

SEK as of Jan. 1, 2024

US$36.8 Million

business Kancera AB Company Profile

Kancera AB Main Stock Listing

OMX: KAN

Market Capitalization History of Kancera AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Kancera AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr370.4 M 42.35%
Jan. 1, 2023 kr260.2 M -52.19%
Jan. 1, 2022 kr544.3 M -60.03%
Jan. 1, 2021 kr1.36 B 185.42%
Jan. 1, 2020 kr477.2 M -50.09%
Jan. 1, 2019 kr956.1 M -40.70%
Jan. 1, 2018 kr1.61 B -21.61%
Jan. 1, 2017 kr2.06 B -41.23%
Jan. 1, 2016 kr3.50 B -31.20%
Jan. 1, 2015 kr5.09 B 134.92%
Jan. 1, 2014 kr2.17 B 163.83%
Jan. 1, 2013 kr820.6 M -47.43%
Jan. 1, 2012 kr1.56 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Kancera AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Kancera AB has the following listings and related stock indices.


Stock: OMX: KAN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.